Medicus Pharma (MDCX)
0.37
-0.02 (5.13%)
Upcoming Events
Latest Headlines
Medicus Pharma gets FDA feedback and IRB nod for smaller Phase 2 trial
July 16, 2026 7:30 AM - StreetInsider
Medicus Pharma Receives Positive FDA Feedback and Central IRB Approval for Optimized Phase 2 Teverelix® Novel Study in Acute Urinary Retention
July 16, 2026 7:30 AM - StreetInsider
New to The Street Show #760 Airs Tonight on Bloomberg Television Across the U.S. on Independence Day Featuring Sullivan & Cromwell’s Frank Aquila, Medicus Pharma, PetVivo, FreeCast and YY Group
July 4, 2026 12:27 PM - StreetInsider
Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026
June 22, 2026 7:30 AM - StreetInsider
New to The Street broadcasts show #758 TODAY AT 6:30 PM ET on BLOOMBERG TELEVISION ACROSS THE UNITED STATES, LATIN AMERICA, AND MENA
June 20, 2026 1:30 PM - StreetInsider
Medicus Pharma submits rare pediatric disease designation request for SkinJect
June 15, 2026 7:30 AM - StreetInsider
Medicus Pharma Announces U.S. Food and Drug Administration (FDA) Submission of Rare Pediatric Disease Designation Request for SkinJect® in Gorlin Syndrome
June 15, 2026 7:30 AM - StreetInsider
New to The Street Broadcasting Saturday June 13th 630pm est ACROSS BLOOMBERG TELEVISION IN THE U.S., LATIN AMERICA, AND MENA
June 12, 2026 2:45 PM - StreetInsider
Medicus Pharma starts genomic endometriosis trial in UAE
June 11, 2026 7:30 AM - StreetInsider
Medicus Pharma Initiates Groundbreaking PRECISION-E2 Phase 2a Study of Teverelix® in Endometriosis utilizing the Emirati Genome Program
June 11, 2026 7:30 AM - StreetInsider
Medicus Pharma submits European filing for Teverelix prostate cancer study
June 8, 2026 7:32 AM - StreetInsider
Medicus Pharma Advances Teverelix® Program Towards Registrational Development Targeting High Cardiovascular-Risk Prostate Cancer Patients with Key European Submission
June 8, 2026 7:30 AM - StreetInsider
New to The Street Broadcasts Tonight on Bloomberg Television Across the United States, Latin America, and MENA at 6:30 PM ET
June 6, 2026 11:20 AM - StreetInsider
Form 424B3 Medicus Pharma Ltd.
June 4, 2026 5:04 PM - SEC Filing
Form 8-K Medicus Pharma Ltd. For: Jun 03
June 4, 2026 4:31 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: Smith Andrew Alasdair
June 4, 2026 4:20 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: Rodgers Cathy McMorris
June 4, 2026 4:18 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: Raju Ajay
June 4, 2026 4:17 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: Mehmud Faisal
June 4, 2026 4:15 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: May Sara R.
June 4, 2026 4:13 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: MAHAFFY PATRICK J
June 4, 2026 4:13 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: Kaiser Larry
June 4, 2026 4:11 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: FISHMAN BARRY
June 4, 2026 4:09 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: Ciaruffoli Robert J.
June 4, 2026 4:08 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: Brennan Edward J.
June 4, 2026 4:06 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: Bonner Carolyn F.
June 4, 2026 4:04 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: Bokhari Raza
June 4, 2026 4:02 PM - SEC Filing
Form 4 Medicus Pharma Ltd. For: Jun 03 Filed by: Ashton William
June 4, 2026 4:00 PM - SEC Filing
Medicus Pharma Advances SkinJect® into Registrational Development for Gorlin Syndrome
June 3, 2026 8:00 AM - StreetInsider
New to The Street Broadcasts Nationwide on Bloomberg Television Featuring "Opportunities To Consider(TM)" Across Artificial Intelligence, Healthcare Innovation, Fintech, Digital Assets, and Commoditie
May 30, 2026 11:55 AM - StreetInsider
Medicus Pharma secures $22 million structured financing facility
May 28, 2026 8:06 AM - StreetInsider
Medicus Pharma Announces $22 Million Non-Dilutive Financing
May 28, 2026 8:00 AM - StreetInsider
Form 424B3 Medicus Pharma Ltd.
May 28, 2026 6:02 AM - SEC Filing
Form 8-K Medicus Pharma Ltd. For: May 20
May 27, 2026 4:45 PM - SEC Filing
New to The Street Broadcasts Episode 753 Today at 6:30 PM EST Across Bloomberg Television U.S., MENA, and Latin America Featuring Leaders in VR Defense Training, AI Streaming, Healthcare Innovation, a
May 23, 2026 12:25 PM - StreetInsider
New to The Street's Show #753 Airs Nationwide on Bloomberg Television Across the U.S., MENA and Latin America Featuring FreeCast (NASDAQ:CAST), Stardust Power (NASDAQ:SDST), Lost Soldier Oil and Gas,
May 16, 2026 7:05 AM - StreetInsider
Medicus Pharma Ltd. (MDCX) Tops Q1 EPS by 30c
May 14, 2026 5:28 PM - StreetInsider
Form 424B3 Medicus Pharma Ltd.
May 14, 2026 4:50 PM - SEC Filing
Medicus Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 14, 2026 4:30 PM - StreetInsider
Form 10-Q Medicus Pharma Ltd. For: Mar 31
May 14, 2026 4:08 PM - SEC Filing
New to The Street Broadcasts Show #752 on Bloomberg Television Featuring Graphene Manufacturing Group (OTCQX:GMGRF), T-REX Acquisition Corp (NASDAQ:TRXA), KITON, and Roadzen (NASDAQ:RDZN)
May 9, 2026 12:55 PM - StreetInsider
Medicus Pharma reports positive dose response in skin cancer trial
May 6, 2026 7:30 AM - StreetInsider
Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response
May 6, 2026 7:30 AM - Globe NewsWire
Form SCHEDULE 13G/A Medicus Pharma Ltd. Filed by: Raju Ajay
May 5, 2026 10:55 AM - SEC Filing
Form ARS Medicus Pharma Ltd. For: Dec 31
May 4, 2026 4:36 PM - SEC Filing
Form DEF 14A Medicus Pharma Ltd. For: Jun 03
May 4, 2026 6:03 AM - SEC Filing
GLOBAL MARKETS SPOTLIGHT: New to The Street Show #748 Delivers High-Impact CEO Interviews and Spotlight TV Commercials Across Bloomberg to 250M+ Households Worldwide
May 1, 2026 2:30 PM - StreetInsider
Form 424B3 Medicus Pharma Ltd.
April 30, 2026 6:15 AM - SEC Filing
Form 10-K/A Medicus Pharma Ltd. For: Dec 31
April 29, 2026 5:21 PM - SEC Filing
Medicus Pharma CEO meets with House lawmakers on rare disease treatment
April 27, 2026 7:39 AM - StreetInsider
Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill
April 27, 2026 7:38 AM - StreetInsider
Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill
April 27, 2026 7:30 AM - Globe NewsWire
Form 424B3 Medicus Pharma Ltd.
April 27, 2026 6:02 AM - SEC Filing
New to The Street Broadcasts Show #746 Tonight on Bloomberg Television 6:30PM EST Featuring NRx Pharma (NASDAQ:NRXP), Performance Golf, Lost Soldier Oil & Gas, Dr. Lee Gause, and CISO Global
April 25, 2026 12:55 PM - StreetInsider
Form 8-K Medicus Pharma Ltd. For: Apr 21
April 24, 2026 5:27 PM - SEC Filing
Form 424B3 Medicus Pharma Ltd.
April 23, 2026 7:00 PM - SEC Filing
Full Article List
